Trial intelligence / Profile preview

Intraovarian platelet-rich plasma for diminished ovarian reserve in infertile women

IRCT20160722029027N14Phase 2Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jan 2024
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of platelet-rich plasma in infertility and Diminished Ovarian Reserve (DOR), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: ovarian reserve. Started Jan 2024; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

infertilityDiminished Ovarian Reserve (DOR)

Beyond the preview

Go deeper on IRCT20160722029027N14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20160722029027N14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call